Physician profile
Philis Ransom
NPI 1396914545
$20,104.91
in general payments reported to CMS, 2019-2025
11 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.55 · 2021: $228 · 2023: $17K · 2024: $3,122 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $19,500.00 |
| Food and Beverage | $342.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,532.11 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Aspira Women'S Health INC | $194.29 | 2021 | |
| Organon LLC | $145.39 | 2021-2025 | Nexplanon |
| Sage Therapeutics, LLC | $71.78 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $46.06 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $36.88 | 2024-2025 | Myfembree |
| Smith+Nephew, INC. | $26.38 | 2025 | Pico 14 |
| Abbvie INC. | $17.51 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.04 | 2019 | |
| Glaxosmithkline, LLC. | $11.67 | 2021 | |
| Evofem Biosciences, INC. | $5.80 | 2025 | Phexxi, Solosec, Phexx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philis Ransom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.